Search Results - "Gigan, M."

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study by Lahouati, M., Cazanave, C., Labadie, A., Gohier, P., Guirlé, L., Desclaux, A., Gigan, M., Malvy, D., Pedeboscq, S., Xuereb, F., Duvignaud, A.

“…The aim of this study was to describe the outcomes of targeted COVID-19 treatments in immunocompromised patients with asymptomatic or mild COVID-19 during the…”
Get full text

Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases by Djabarouti, S, Mora, P, Lahouati, M, Gigan, M, d'Houdain, N, Sourisseau, B, Chambord, J, Xuereb, F

“…The pharmacokinetics of drugs, such as immunosuppressants, justify the need of measuring their blood concentrations in order to adjust their dosage…”
Get full text

Intérêt des dosages pharmacologiques d’immunosuppresseurs et immunomodulateurs dans la prise en charge des maladies autoimmunes by Djabarouti, S., Mora, P., Lahouati, M., Gigan, M., d’Houdain, N., Sourisseau, B., Chambord, J., Xuereb, F.

Get full text

Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases by Djabarouti, S, Mora, P, Lahouati, M, Gigan, M, d'Houdain, N, Sourisseau, B, Chambord, J, Xuereb, F

Get full text

Principales complicaciones asociadas a la administración de quimioterapia intraperitoneal y endovenosa en pacientes con cáncer de ovario by Palmés Ferrera, Mercedes, Andersson Vila, Cassandra Ixena, Barrera Reyes, Maria del Carmen, García Gigán, Maria del Carmen, Graells Piqué, Maria Alba, Gómez Rodríguez, Esther

“…Antecedentes: El cáncer de ovario causa más muertes que cualquier otro tipo de cáncer ginecológico. La mayoría de casos se diagnostican en una etapa avanzada…”
Get full text